| Ident. | Authors (with country if any) | Title |
|---|
| 000013 (2017) |
Dami Collier [Royaume-Uni] ; Collins Iwuji [Afrique du Sud, Royaume-Uni] ; Anne Derache [Afrique du Sud, France] ; Tulio De Oliveira [Afrique du Sud] ; Nonhlanhla Okesola [Afrique du Sud] ; Alexandra Calmy [Suisse] ; Francois Dabis [France] ; Deenan Pillay [Royaume-Uni, Afrique du Sud] ; Ravindra K. Gupta [Royaume-Uni, Afrique du Sud] | Virological Outcomes of Second-line Protease Inhibitor–Based Treatment for Human Immunodeficiency Virus Type 1 in a High-Prevalence Rural South African Setting: A Competing-Risks Prospective Cohort Analysis |
| 000084 (2017) |
Sibongile Walaza ; Stefano Tempia ; Andries Dreyer ; Halima Dawood [Afrique du Sud] ; Ebrahim Variava ; Neil A. Martinson [Afrique du Sud] ; Jocelyn Moyes ; Adam L. Cohen [Géorgie (pays)] ; Nicole Wolter ; Claire Von Mollendorf ; Anne Von Gottberg ; Sumayya Haffejee [Afrique du Sud] ; Florette Treurnicht ; Orienka Hellferscee ; Nazir Ismail ; Cheryl Cohen | The Burden and Clinical Presentation of Pulmonary Tuberculosis in Adults With Severe Respiratory Illness in a High Human Immunodeficiency Virus Prevalence Setting, 2012-2014. |
| 000092 (2017) |
Pamela M. Murnane [États-Unis] ; Renate Strehlau [Afrique du Sud] ; Stephanie Shiau [États-Unis] ; Faeezah Patel [Afrique du Sud] ; Ndileke Mbete [Afrique du Sud] ; Gillian Hunt [Afrique du Sud] ; Elaine J. Abrams [Afrique du Sud] ; Ashraf Coovadia [Afrique du Sud] ; Louise Kuhn [États-Unis] | Switching to Efavirenz Versus Remaining on Ritonavir-boosted Lopinavir in Human Immunodeficiency Virus-infected Children Exposed to Nevirapine: Long-term Outcomes of a Randomized Trial. |
| 000186 (2017) |
Clement G. Adu-Gyamfi ; Tracy Snyman [Afrique du Sud] ; Christopher J. Hoffmann [États-Unis] ; Neil A. Martinson [Afrique du Sud] ; Richard E. Chaisson [États-Unis] ; Jaya A. George [Afrique du Sud] ; Melinda S. Suchard | Plasma Indoleamine 2, 3-Dioxygenase, a Biomarker for Tuberculosis in Human Immunodeficiency Virus-Infected Patients. |
| 000217 (2017) |
Anwar Suleman Mall [États-Unis] ; Habtom Habte [Afrique du Sud] ; Yolanda Mthembu [États-Unis] ; Julia Peacocke [États-Unis] ; Corena De Beer [Afrique du Sud] | Mucus and Mucins: do they have a role in the inhibition of the human immunodeficiency virus? |
| 000221 (2017) |
Elizabeth S. Mayne [Afrique du Sud] ; Jaya A. George | Mortal allies: human immunodeficiency virus and noncommunicable diseases. |
| 000262 (2017) |
Sheela V. Shenoi ; Anthony P. Moll ; Ralph P. Brooks ; Tassos Kyriakides [États-Unis] ; Laurie Andrews ; Teja Kompala ; Devesh Upadhya [États-Unis] ; Frederick L. Altice ; Francois J. Eksteen [Afrique du Sud] ; Gerald Friedland | Integrated Tuberculosis/Human Immunodeficiency Virus Community-Based Case Finding in Rural South Africa: Implications for Tuberculosis Control Efforts. |
| 000266 (2017) |
Kathleen Squires [États-Unis] ; Linda-Gail Bekker [Afrique du Sud] ; Christine Katlama ; Yazdan Yazdanpanah [France] ; Yan Zhou [États-Unis] ; Anthony J. Rodgers [États-Unis] ; Mark J. Dinubile [États-Unis] ; Peter A. Sklar [États-Unis] ; Randi Y. Leavitt [États-Unis] ; Hedy Teppler [États-Unis] | Influence of Sex/Gender and Race on Responses to Raltegravir Combined With Tenofovir-Emtricitabine in Treatment-Naive Human Immunodeficiency Virus-1 Infected Patients: Pooled Analyses of the STARTMRK and QDMRK Studies |
| 000289 (2017) |
Michael J. Vinikoor ; Edford Sinkala ; Roma Chilengi ; Lloyd B. Mulenga ; Benjamin H. Chi [États-Unis] ; Zude Zyambo ; Christopher J. Hoffmann [États-Unis] ; Michael S. Saag ; Mary-Ann Davies [Afrique du Sud] ; Matthias Egger [Suisse] ; Gilles Wandeler [Suisse] | Impact of Antiretroviral Therapy on Liver Fibrosis Among Human Immunodeficiency Virus-Infected Adults With and Without HBV Coinfection in Zambia. |
| 000295 (2017) |
Anushka Naidoo ; Kogieleum Naidoo ; Veron Ramsuran [Afrique du Sud] ; Millidhashni Reddy ; Nesri Padayatchi | Hyperbilirubinemia in atazanavir-treated human immunodeficiency virus-infected patients: the impact of the UGT1A1*28 allele. |
| 000303 (2017) |
Maanda Mudau [Afrique du Sud] ; Remco P. Peters [Afrique du Sud] ; Lindsey De Vos [Afrique du Sud] ; Dawie H. Olivier [Afrique du Sud] ; Dvora J Davey [Afrique du Sud] ; Edwin S. Mkwanazi [Afrique du Sud] ; James A. Mcintyre [Afrique du Sud] ; Jeffrey D. Klausner [États-Unis] ; Andrew Medina-Marino [Afrique du Sud] | High prevalence of asymptomatic sexually transmitted infections among human immunodeficiency virus-infected pregnant women in a low-income South African community. |
| 000386 (2017) |
Jean-Christophe Beghin [Belgique] ; Jean Ruelle [Belgique] ; Etienne Sokal [Belgique] ; Antoine Bachy [Belgique] ; Malini Krishna [Afrique du Sud] ; Leslie Hall [Afrique du Sud] ; Patrick Goubau [Belgique] ; Dimitri Van Der Linden [Belgique] | Effectiveness of the South African expanded program of immunization against hepatitis B in children infected with human immunodeficiency virus-1 living in a resource-limited setting of Kwazulu-Natal. |
| 000419 (2017) |
Michael Strauss [Afrique du Sud] ; Gavin George ; Bruce Rhodes | Designing Human Immunodeficiency Virus Counselling and Testing Services to Maximize Uptake Among High School Learners in South Africa: What Matters? |
| 000450 (2017) |
Paul K. Drain ; Elena Losina ; Sharon M. Coleman ; Janet Giddy [Afrique du Sud] ; Douglas Ross [Afrique du Sud] ; Jeffrey N. Katz ; Kenneth A. Freedberg ; Ingrid V. Bassett | Clinic-Based Urinary Lipoarabinomannan as a Biomarker of Clinical Disease Severity and Mortality Among Antiretroviral Therapy-Naive Human Immunodeficiency Virus-Infected Adults in South Africa |
| 000647 (2015) |
Devesh Upadhya [États-Unis] ; Anthony P. Moll [Afrique du Sud] ; Ralph P. Brooks [États-Unis] ; Gerald Friedland [États-Unis] ; Sheela V. Shenoi [États-Unis] | What motivates use of community-based human immunodeficiency virus testing in rural South Africa? |
| 000701 (2015) |
Gerald S. Bloomfield [États-Unis] ; Fawaz Alenezi [États-Unis] ; Felix A. Barasa [Kenya] ; Rebecca Lumsden [États-Unis] ; Bongani M. Mayosi [Afrique du Sud] ; Eric J. Velazquez [États-Unis] | Human Immunodeficiency Virus and Heart Failure in Low- and Middle-Income Countries |
| 000922 (2013) |
J M Frantz [Afrique du Sud] ; A. Murenzi | The physical activity levels among people living with human immunodeficiency virus/acquired immunodeficiency syndrome receiving high active antiretroviral therapy in Rwanda. |
| 000928 (2013) |
Louis-Jacques Van Bogaert [Afrique du Sud] | The impact of human immunodeficiency virus infection on cervical preinvasive and invasive neoplasia in South Africa. |
| 000929 (2013) |
Linda Lee Stephens [Afrique du Sud] ; Carmen Catherine-Ann Swanepoel ; Beverley Ann Van Rooyen ; Emmanuel Akinola Abayomi | The human immunodeficiency virus, (HIV-1), pandemic: cellular therapies, stem cells and biobanking. |
| 000A20 (2013) |
Sumaya Mall [Afrique du Sud] ; Katherine Sorsdahl ; Helen Struthers ; John A. Joska | Mental health in primary human immunodeficiency virus care in South Africa: a study of provider knowledge, attitudes, and practice. |
| 000A39 (2013) |
Cathy Nisha John [Afrique du Sud] ; Lawrence Xavier Stephen ; Charlene Wilma Joyce Africa | Is human immunodeficiency virus (HIV) stage an independent risk factor for altering the periodontal status of HIV-positive patients? A South African study. |
